加强淋病奈瑟菌对抗菌药物耐药性的全球监测：强化淋球菌抗菌药物监测计划。
Strengthening Global Surveillance for Antimicrobial Drug-Resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Program.
出版信息
Emerg Infect Dis. 2017 Oct;23(13):S47-52. doi: 10.3201/eid2313.170443.
Abstract
Monitoring trends in antimicrobial drug-resistant Neisseria gonorrhoeae is a critical public health and global health security activity because the number of antimicrobial drugs available to treat gonorrhea effectively is rapidly diminishing. Current global surveillance methods for antimicrobial drug-resistant N. gonorrhoeae have many limitations, especially in countries with the greatest burden of disease. The Enhanced Gonococcal Antimicrobial Surveillance Program is a collaboration between the World Health Organization and the Centers for Disease Control and Prevention. The program aims to monitor trends in antimicrobial drug susceptibilities in N. gonorrhoeae by using standardized sampling and laboratory protocols; to improve the quality, comparability, and timeliness of gonococcal antimicrobial drug resistance data across multiple countries; and to assess resistance patterns in key populations at highest risk for antimicrobial drug-resistant gonorrhea so country-specific treatment guidelines can be informed.
摘要
监测耐抗生素淋病奈瑟菌的趋势是一项至关重要的公共卫生和全球卫生安全活动，因为可有效治疗淋病的抗生素药物数量正在迅速减少。目前针对耐抗生素淋病奈瑟菌的全球监测方法存在诸多局限性，在疾病负担最大的国家尤其如此。强化淋球菌抗生素监测计划是世界卫生组织和疾病预防控制中心之间的一项合作。该计划旨在通过使用标准化的抽样和实验室方案来监测淋病奈瑟菌对抗生素药物敏感性的趋势；提高多个国家淋病奈瑟菌抗抗生素药物耐药性数据的质量、可比性和及时性；评估高危人群中的耐药模式，以便为制定特定国家的治疗指南提供信息。
相似文献
1
Strengthening Global Surveillance for Antimicrobial Drug-Resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Program.加强淋病奈瑟菌对抗菌药物耐药性的全球监测：强化淋球菌抗菌药物监测计划。
Emerg Infect Dis. 2017 Oct;23(13):S47-52. doi: 10.3201/eid2313.170443.
2
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目，美国 27 个监测点，2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
3
Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.淋病奈瑟菌在乌干达新实施的监测项目中的抗药性：监测报告。
JMIR Public Health Surveill. 2020 Jun 10;6(2):e17009. doi: 10.2196/17009.
4
Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.回顾性分析拉丁美洲和加勒比地区淋病奈瑟菌分离株的抗菌药物敏感性趋势（2000-2009 年）显示，对环丙沙星、阿奇霉素的耐药性不断增加，对头孢曲松的敏感性降低。
Sex Transm Dis. 2012 Oct;39(10):813-21. doi: 10.1097/OLQ.0b013e3182631c9f.
5
World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.世界卫生组织全球淋球菌抗菌监测项目（WHO GASP）：对新数据和证据的综述，以为国际合作行动和研究工作提供信息
Sex Health. 2019 Sep;16(5):412-425. doi: 10.1071/SH19023.
6
Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.泰国曼谷淋病奈瑟菌菌株的抗菌药敏性：1994 - 1995年
Sex Transm Dis. 1997 Mar;24(3):142-8. doi: 10.1097/00007435-199703000-00004.
7
Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016.2011 年至 2016 年亚太地区淋病奈瑟菌头孢曲松和阿奇霉素药敏数据的系统评价和调查。
PLoS One. 2019 Apr 3;14(4):e0213312. doi: 10.1371/journal.pone.0213312. eCollection 2019.
8
Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.淋病奈瑟菌在男男性行为者和仅与女性发生性行为的男性中的抗微生物药物耐药性：淋球菌分离株监测项目，2005-2010 年。
Ann Intern Med. 2013 Mar 5;158(5 Pt 1):321-8. doi: 10.7326/0003-4819-158-5-201303050-00004.
9
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.2009-2016 年，欧盟/欧洲经济区淋病奈瑟菌分离株的抗菌药物敏感性/耐药性与患者的性别、性取向和感染解剖部位的关系。
BMC Infect Dis. 2021 Mar 18;21(1):273. doi: 10.1186/s12879-021-05931-0.
10
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.欧洲淋球菌抗菌药物监测计划（Euro-GASP）恰当地反映了欧盟/欧洲经济区淋病奈瑟菌的抗菌药物耐药情况。
BMC Infect Dis. 2019 Dec 10;19(1):1040. doi: 10.1186/s12879-019-4631-x.
引用本文的文献
1
Metagenomic analysis of human, animal, and environmental samples identifies potential emerging pathogens, profiles antibiotic resistance genes, and reveals horizontal gene transfer dynamics.对人类、动物和环境样本进行宏基因组分析，可识别潜在的新兴病原体，分析抗生素抗性基因图谱，并揭示水平基因转移动态。
Sci Rep. 2025 Apr 9;15(1):12156. doi: 10.1038/s41598-025-90777-8.
2
The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization.新型 2024 年世卫组织淋病奈瑟菌参考菌株，用于全球实验室调查的质量保证，取代世卫组织淋病奈瑟菌参考菌株 - 表型、遗传和参考基因组特征。
J Antimicrob Chemother. 2024 Aug 1;79(8):1885-1899. doi: 10.1093/jac/dkae176.
3
High prevalence of ceftriaxone-resistant and XDR in several cities of Cambodia, 2022-23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP).2022 - 23年柬埔寨多个城市头孢曲松耐药和广泛耐药的高流行率：世界卫生组织强化淋球菌抗菌药物监测计划（EGASP）
JAC Antimicrob Resist. 2024 Apr 4;6(2):dlae053. doi: 10.1093/jacamr/dlae053. eCollection 2024 Apr.
4
Time Required for Nanopore Whole-Genome Sequencing of Neisseria gonorrhoeae for Identification of Phylogenetic Relationships.淋病奈瑟菌全基因组纳米孔测序鉴定系统发育关系所需时间。
J Infect Dis. 2023 Nov 2;228(9):1179-1188. doi: 10.1093/infdis/jiad170.
5
Investigating point-of-care diagnostics for sexually transmitted infections and antimicrobial resistance in antenatal care in Zimbabwe (IPSAZ): protocol for a mixed-methods study.在津巴布韦的产前护理中调查即时检测性传播感染和抗菌药物耐药性的方法（IPSAZ）：一项混合方法研究的方案。
BMJ Open. 2023 Apr 20;13(4):e070889. doi: 10.1136/bmjopen-2022-070889.
6
Laboratory-based surveillance of antimicrobial resistance in regions of Kenya: An assessment of capacities, practices, and barriers by means of multi-facility survey.肯尼亚地区基于实验室的抗菌药物耐药性监测：多机构调查评估能力、实践和障碍
Front Public Health. 2022 Nov 28;10:1003178. doi: 10.3389/fpubh.2022.1003178. eCollection 2022.
7
National surveillance of antimicrobial susceptibility and epidemiological data of gonorrhoea patients across Brazil, 2018-20.2018 - 2020年巴西淋病患者抗菌药物敏感性及流行病学数据的全国监测。
JAC Antimicrob Resist. 2022 Jul 5;4(4):dlac076. doi: 10.1093/jacamr/dlac076. eCollection 2022 Aug.
8
Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.2015-2020 年乌干达实施世界卫生组织全球抗菌药物耐药性监测系统：使用国家监测数据的混合方法研究。
JMIR Public Health Surveill. 2021 Oct 21;7(10):e29954. doi: 10.2196/29954.
9
Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.耐抗生素淋病奈瑟菌的流行病学、治疗方法和疫苗研发：当前策略和未来方向。
Drugs. 2021 Jul;81(10):1153-1169. doi: 10.1007/s40265-021-01530-0. Epub 2021 Jun 7.
10
A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch.Pathogenwatch 上的淋病奈瑟菌基因组流行病学和抗微生物药物耐药性预测的社区驱动资源。
Genome Med. 2021 Apr 19;13(1):61. doi: 10.1186/s13073-021-00858-2.
本文引用的文献
1
Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA.美国夏威夷淋病奈瑟菌的阿奇霉素耐药性及头孢曲松敏感性降低
Emerg Infect Dis. 2017 May;23(5):830-832. doi: 10.3201/eid2305.170088.
2
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目，美国 27 个监测点，2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
3
Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea.双重抗菌疗法治疗淋病失败
N Engl J Med. 2016 Jun 23;374(25):2504-6. doi: 10.1056/NEJMc1512757.
4
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting.基于系统评价和全球报告的2012年四种可治愈性传播感染的患病率和发病率全球估计
PLoS One. 2015 Dec 8;10(12):e0143304. doi: 10.1371/journal.pone.0143304. eCollection 2015.
5
Australian Gonococcal Surveillance Programme annual report, 2014.《2014年澳大利亚淋病监测项目年度报告》
Commun Dis Intell Q Rep. 2015 Sep 30;39(3):E347-54.
6
Sexually transmitted diseases treatment guidelines, 2015.《2015年性传播疾病治疗指南》
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137.
7
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.21世纪淋病奈瑟菌的抗菌药物耐药性：过去、演变及未来
Clin Microbiol Rev. 2014 Jul;27(3):587-613. doi: 10.1128/CMR.00010-14.
8
2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.2012年成人淋病诊断与治疗欧洲指南。
Int J STD AIDS. 2013 Feb;24(2):85-92. doi: 10.1177/0956462412472837.
9
UK national guideline for the management of gonorrhoea in adults, 2011.《2011年英国成人淋病管理国家指南》
Int J STD AIDS. 2011 Oct;22(10):541-7. doi: 10.1258/ijsa.2011.011267.
10
From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.从流行病学协同作用到公共卫生政策与实践：其他性传播疾病对艾滋病毒感染性传播的影响
Sex Transm Infect. 1999 Feb;75(1):3-17. doi: 10.1136/sti.75.1.3.
Zotero 插件